Bellicum Pharmaceuticals Inc.: Molecular switch technology and co-stim domains enables pharmacologic control over cells for enhanced efficacy and safety. Lead (registrational EU) program: Ph2 for rivo-cel (alpha/beta addback T-cell therapy for post allogeneic HSTC in non-malignant and malignant diseases). Positive late interim analysis on rivo-cel exp at ASH 2018; full dataset (N=234) exp H1 19. BPX-601: GoCAR-T featuring iMC (inducible MyD88/CD40) activation switch targeting PSCA expressing solid tumors; BPX-701: TCR targeting PRAME.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
USA
Clinical Stage
Phase l or ll
Disease Space
Immuno-Oncology, Oncology, Rare Disease
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
<100MM
Therapeutic Modalities
Cell Therapy
Website:
Profiles:
Address:
2130 West Holcombe Boulevard, Suite 800
Texas Life Science Plaza
Houston, TX 77030
United States

Company Participants at Bellicum Pharmaceuticals Analyst and Investor Meeting at ASH

  • Rick Fair, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Bellicum Pharmaceuticals Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Baker Bros. Advisors LP 6.18 2,677,818 2.17 13F 2019-09-30
Renaissance Technologies LLC 6.00 2,601,064 2.11 13F 2019-09-30
Nikko Asset Management Americas, Inc. 5.43 2,356,277 1.91 13F 2019-09-30
Sumitomo Mitsui Trust Holdings, Inc. 5.43 2,356,277 1.91 13F 2019-09-30
The Vanguard Group, Inc. 4.11 1,781,328 1.44 Funds 2019-10-31
Vanguard Group, Inc. (Subfiler) 4.08 1,770,999 1.43 13F 2019-09-30
Frazier Management LLC 2.42 1,051,441 0.85 13F 2019-09-30
Armistice Capital LLC 2.39 1,034,962 0.84 13F 2019-09-30
BlackRock Institutional Trust Co. NA 1.93 838,004 0.68 13F 2019-09-30
Sphera Funds Management Ltd. 1.73 750,000 0.61 13F 2019-09-30

Top 10 Holders of BELLICUM PHARMACEUTICALS PFD SR 1

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Tavistock Life Sciences Co. (Investment Management) 948.03 5,133,600 4.16 Stakes 2019-08-16
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2019 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.